著者
Toshihiro Ide Takeru Kawanami Makoto Eriguchi Hideo Hara
出版者
The Japanese Society of Internal Medicine
雑誌
Internal Medicine (ISSN:09182918)
巻号頁・発行日
pp.8709-21, (Released:2022-02-08)
参考文献数
23
被引用文献数
21

We herein report a case of MOG antibody-associated disease after SARS-CoV-2 infection. A 24-year-old woman developed unilateral optic neuritis 3 weeks after contracting COVID-19, followed by intracranial demyelinating lesions and myelitis. Since serum anti-MOG antibody was positive, we diagnosed MOG antibody-associated disease. Immunotherapy with steroids resulted in the rapid improvement of neurological symptoms. This is a suggestive case, as there are no reports of MOG antibody-associated disease with multiple neurological lesions occurring after COVID-19. The response to immunotherapy was favorable. This case suggests that it is important to measure anti-MOG antibodies in patients who develop inflammatory neurological disease after COVID-19.